DUBAI—The Emirates Health Economics Society (EHES) will host its first health industry conference since its foundation in July 2020. Under the theme “Financing the Future of Sustainable Innovation”, the hybrid-format conference will take place on November 28-30, 2021, at Jumeirah Emirates Towers, Dubai, and will have a unique focus on the intersection between scientific innovation and economics and the implications of both on the healthcare system in the United Arab Emirates (UAE).
A diverse range of workshops and plenary sessions will feature expert speakers including economists, health scientists, insurance professionals and healthcare providers and a keynote lecture will be given by Dr Awad Mataria, Director of Universal Health Coverage/Health Systems at the World Health Organisation. Sessions over the three-day period will include presentations and panel discussions on a range of topics including: the role of economics in healthcare policy development, the evolution of insurance, and innovation in sustainability in payer models.
Founded in July 2020, under the umbrella of the Emirates Medical Association (EMA), EHES has a mission to drive innovation, research, and inter-disciplinary collaboration through promotion of education and science. In addition, the conference will serve as a forum for sharing the most advanced thinking and up-to-date information about health economics in the UAE for the benefit of all industry stakeholders and regulators.
“Financing the Future of Sustainable Innovation” is hosted in partnership with the Pharmaceutical Research & Manufacturers in the Gulf (PHRMAG), the industry group that represents the region’s leading innovative biopharmaceutical research companies.
During the conference, the PHRMAG Health Care Financing and Insurance Working Group will host two workshops to address current and anticipated challenges, and to explore potential initiatives with healthcare stakeholders and partners to further boost a patient a patient-centred, equitable, and sustainable health care system that creates value for patients and society.
Dr Sara Al Dallal, President, Emirates Health Economics Society says: “Our partnership with the industry is what keeps the science in our field evolving. We are delighted to have gathered such a diverse group of leading figures to discuss such a range of important issues in heath economics. We look forward to addressing current and anticipated challenges and exploring potential initiatives with our strategic partners to support the development of advanced healthcare systems in the UAE.”
Speaking on behalf of PHRMAG, Mohammed Ezz Eldin, President & Gulf Cluster Head Novartis and Chairman of PHRMAG said: “Since 1995, PHRMAG has played a significant role in the region representing the industry in the healthcare sector with the goal to foster collaboration and partnership with health authorities and different stakeholders in the healthcare system, to enhance access to innovation for patients in the UAE.”
Jamie Phares Managing Director of Janssen GCC, the Pharmaceutical Companies of Johnson & Johnson and Executive Committee Member of PHARMAG, and sponsor of the PHRMAG Health Care Financing and Insurance Working Group, said “Emirates Health Economics Society is a strategic partner of PHRMAG. We have developed a great collaboration to identify unmet needs to enhance the efficiency of the healthcare system in the UAE. Today’s collaboration with EHES furthers our efforts to forge a roadmap towards financing innovation in healthcare, supporting the UAE ecosystem and national agenda for a healthier and happier community.”
-Ends-
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
